Liver histopathology and liver and serum alanine aminotransferase and alkaline phosphatase activities in epileptic dogs receiving phenobarbital. - Wikidata - awgldk - TriplyDB

Liver histopathology and liver and serum alanine aminotransferase and alkaline phosphatase activities in epileptic dogs receiving phenobarbital.

Liver histopathology and liver and serum alanine aminotransferase and alkaline phosphatase activities in epileptic dogs receiving phenobarbital.

http://www.wikidata.org/entity/Q45309220

about

Antiepileptic drugs' tolerability and safety--a systematic review and meta-analysis of adverse effects in dogs Effects of hepatic drug-metabolizing enzyme induction on clinical pathology parameters in animals and man.Protective role of omega-3 polyunsaturated fatty acid against lead acetate-induced toxicity in liver and kidney of female rats.Toxicological evaluation of methanol leaves extract of Vernonia bipontini Vatke in blood, liver and kidney tissues of mice.Protective effect of Irvingia gabonensis stem bark extract on cadmium-induced nephrotoxicity in rats.International Veterinary Epilepsy Task Force consensus proposal: medical treatment of canine epilepsy in Europe Modulatory effect of protocatechuic acid on cadmium induced nephrotoxicity and hepatoxicity in rats in vivo.Clinical characteristics of epilepsy of unknown origin in the Rottweiler breed.The seizuring cat. Diagnostic work-up and therapy.Liver hypertrophy: a review of adaptive (adverse and non-adverse) changes--conclusions from the 3rd International ESTP Expert Workshop.Epilepsy beyond seizures: a review of the impact of epilepsy and its comorbidities on health-related quality of life in dogs.Quillaja saponaria bark saponin protects Wistar rats against ferrous sulphate-induced oxidative and inflammatory liver damage.Effect of a controlled food-chain mediated exposure to cadmium and arsenic on oxidative enzymes in the tissues of rats.Protective effects of hesperidin on oxidative stress, dyslipidaemia and histological changes in iron-induced hepatic and renal toxicity in rats Lead Induced Hepato-renal Damage in Male Albino Rats and Effects of Activated Charcoal.Silibinin potentially protects arsenic-induced oxidative hepatic dysfunction in rats.Toxic effects of chromium (VI) by maternal ingestion on liver function of female rats and their suckling pups.Modulatory of effect of fresh Amaranthus caudatus and Amaranthus hybridus aqueous leaf extracts on detoxify enzymes and micronuclei formation after exposure to sodium arsenite.Is alanine aminotransferase level a surrogate biomarker of hepatic apoptosis in nonalcoholic fatty liver disease?Effects of sesame oil against after the onset of acetaminophen-induced acute hepatic injury in rats.Toxicological investigation of acute and chronic treatment with Gnidia stenophylla Gilg root extract on some blood parameters and histopathology of spleen, liver and kidney in mice.Correlation of In Vivo and In Vitro Assay Results for Assessment of Free Radical Scavenging Activity of Green Tea Nutraceuticals.Bioactive peptide carnosin protects against lead acetate-induced hepatotoxicity by abrogation of oxidative stress in rats.

P2860

Q28071335-3E6FF524-2C4A-4336-B590-25AA873DF470 Q33618803-FDB9FC71-BA21-4AB9-A1B7-6E63171FE17C Q33862416-A46E6256-DAA3-4F8F-B621-8B51CB7F7807 Q35207217-987DC004-E16E-45F1-A448-4388B774423F Q35620482-45B8B676-8497-407D-BA8A-40E0D7EB9C59 Q35758344-74C517C3-928D-486E-9D7C-2EC8190BE081 Q36234138-3DAEC278-E040-427F-B0ED-7D0820F66FDB Q36259210-B12D845C-ED7B-4920-9EC7-E900200E89BD Q37457534-67750F3F-3841-47DF-98C9-49825F021075 Q38020789-EE4B0FBE-0B4F-472C-8C75-34F9B376D3EF Q38592689-C6651E80-43B7-46F9-9066-6613FF727B53 Q38669683-CB8E0FD9-2230-4EB6-B310-DD7104B53D1E Q41679380-8DE95776-1093-4C37-8FA9-9E81C3C23C4F Q41680899-C2474F85-9F84-4185-9239-A14F2E10ACCE Q41914919-6DEF8428-2DFE-44BC-82BE-BB4041CC698F Q42722491-D8C9BBFB-AE0D-439E-8D81-334D1A4B33D3 Q42747482-CC147EC9-E658-47E9-BB71-01FCF42BCDEB Q42934949-DC20D9B5-724D-4738-924E-1CE63CE592EA Q43092106-7629AC88-EFFD-46F7-BE58-AD0D23600B3A Q45574649-AFA21C2B-4225-4319-91E8-DAC1A96FD2F2 Q46156669-7F04E523-19D0-445D-AC6F-A83213C718A2 Q46535833-E66C16E4-4693-43F6-BE7B-200812DBCAA3 Q53195741-CA6FAE10-C965-40D7-8971-BD32918ACA31

P2860

Liver histopathology and liver and serum alanine aminotransferase and alkaline phosphatase activities in epileptic dogs receiving phenobarbital.

http://www.wikidata.org/entity/Q45309220

description

2005 nî lūn-bûn

@nan

2005年の論文

@ja

2005年学术文章

@wuu

2005年学术文章

@zh-cn

2005年学术文章

@zh-hans

2005年学术文章

@zh-my

2005年学术文章

@zh-sg

2005年學術文章

@yue

2005年學術文章

@zh

2005年學術文章

@zh-hant

name

Liver histopathology and liver ...... dogs receiving phenobarbital.

@en

Liver histopathology and liver ...... dogs receiving phenobarbital.

@nl

type

label

Liver histopathology and liver ...... dogs receiving phenobarbital.

@en

Liver histopathology and liver ...... dogs receiving phenobarbital.

@nl

prefLabel

Liver histopathology and liver ...... dogs receiving phenobarbital.

@en

Liver histopathology and liver ...... dogs receiving phenobarbital.

@nl

P1433

Q45309220-8BFAC79D-448A-4422-AE4E-D113E2B4FC28

P1476

Q45309220-9B5F4C18-301D-41FB-BD6E-1613BFCDED21

P2093

Q45309220-199C18D5-42C9-4EBB-8390-F3F6D4446A4A

Q45309220-373B32BC-DFEC-4C09-BD1A-9CBDC004BD71

Q45309220-65824626-4593-4FCD-8F66-3EA9B50E22DE

Q45309220-91F575D4-1430-4D29-A371-7A6F7B0DA68C

Q45309220-95E44DF9-5602-4921-A0BD-FD327AA5FE9C

Q45309220-9A2C04BF-2CF2-40FD-96A4-BAED8D76ABC4

Q45309220-9CBB7D49-512C-44F5-B324-02C042AD6C4C

Q45309220-DE950C4E-BE25-4518-BE57-C20EDB2052E4

Q45309220-F5630D6B-37EE-418C-870E-5542F01C4742

Q45309220-FEAA5180-9BF6-4E9B-9B93-98130C448DF5

P2860

Q45309220-03B5073E-63A0-49B6-9276-845F89EBE6F2

Q45309220-45A6223F-DA5F-4F45-8877-1B478604F470

Q45309220-4C3B32CE-F7A9-455D-B839-6511F791BB8D

Q45309220-67AAFC8C-5B0B-408E-A041-062E5E626CA2

Q45309220-7378BF1C-E620-476F-BE39-21165AC5F87B

Q45309220-B57DE911-FAF3-4013-B8AE-283B4AAC70A1

Q45309220-BF811470-EFAD-4749-9E6D-38EB732C6C9D

Q45309220-C5C2E739-1F38-456C-B4A4-B07D16CD74B5

Q45309220-DE5D7236-B054-4855-88A9-526E22F8E5A6

Q45309220-DF9A028B-595E-4C0E-AC2E-61084ADDB8EE

P304

Q45309220-4E6087DA-BB93-43DB-A584-EAD6C38E0226

P31

Q45309220-4E79D380-BD19-4BB2-970E-C955499A2E8D

P356

Q45309220-FB2904A5-B0BE-4EDF-9E3A-2C55AED693B1

P433

Q45309220-41F49D31-1FD0-4096-AFF4-49BE20878B2E

P478

Q45309220-53E8A2F3-C943-43F2-8670-F7F0768172CD

P577

Q45309220-32E92FF2-7BCB-43F6-95BF-273917BAE9E0

P5875

Q45309220-EE7619D9-01FB-4C8A-BB2A-1618AF59EF2F

P698

Q45309220-DAC902CA-C164-4DA4-AB26-917959789227

P356

P1433

Veterinary Pathology

P1476

Liver histopathology and liver ...... dogs receiving phenobarbital.

@en

P2093

A E Cribb

http://www.w3.org/2001/XMLSchema#string

C L Gaskill

http://www.w3.org/2001/XMLSchema#string

D H Shaw

http://www.w3.org/2001/XMLSchema#string

H C J Gelens

http://www.w3.org/2001/XMLSchema#string

J B Miller

http://www.w3.org/2001/XMLSchema#string

J S Mattoon

http://www.w3.org/2001/XMLSchema#string

L M Miller

http://www.w3.org/2001/XMLSchema#string

S A Burton

http://www.w3.org/2001/XMLSchema#string

S L Ihle

http://www.w3.org/2001/XMLSchema#string

W E Hoffmann

http://www.w3.org/2001/XMLSchema#string

P2860

Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: procedure and some applications

A perspective on copper and liver disease in the dog.

Induction of drug-metabolizing enzymes: mechanisms and consequences.

Anticonvulsant therapy in small animals.

Ethoxy-, pentoxy- and benzyloxyphenoxazones and homologues: a series of substrates to distinguish between different induced cytochromes P-450.

Phenobarbital induction of CYP2B1, CYP2B2, and CYP3A1 in rat liver: genetic differences in a common regulatory mechanism.

Serum alkaline phosphatase isoenzyme profiles in phenobarbital-treated epileptic dogs.

Induction of alkoxyresorufin O-dealkylases, epoxide hydrolase, and liver weight gain: correlation with liver tumor-promoting potential in a series of barbiturates.

Inhibition of cytochromes P450 by nitric oxide and a nitric oxide-releasing agent.

Changes in serum thyroxine and thyroid-stimulating hormone concentrations in epileptic dogs receiving phenobarbital for one year

P304

147-160

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1354/VP.42-2-147

http://www.w3.org/2001/XMLSchema#string

P433

2

http://www.w3.org/2001/XMLSchema#string

P478

42

http://www.w3.org/2001/XMLSchema#string

P577

2005-03-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

7981693

http://www.w3.org/2001/XMLSchema#string

P698

15753468

http://www.w3.org/2001/XMLSchema#string